Making clinical diagnoses affordable
Nature Medicine
August 1, 2011
An inexpensive technology that would allow for early detection of infectious diseases in resource-limited and remote settings is presented in a new study published online this week in Nature Medicine.
A challenge for science and engineering is to develop technologies that improve human health in the poorest regions of the world, which may not have reliable access to lab areas for clinical testing.
Samuel Sia and his colleagues integrated new procedures for manufacturing, fluid handling and signal detection, into a single, economical, easy-to-use assay for infectious diseases — the “mChip” assay. The researchers tested the ‘mChip’ in Rwanda on hundreds of locally collected blood samples and found excellent performance in the diagnosis of HIV and syphilis using only one microliter of blood, with a sensitivity that rivals those of reference clinical assays performed in labs.
doi: 10.1038/nm.2408
Research highlights
-
Nov 26
Evolution: Ancient bird sticks its big beak into the evolutionary recordNature
-
Nov 25
Zoology: Mineral armour discovered in insectsNature Communications
-
Nov 24
Neuroscience: Social isolation evokes craving responses in the human brainNature Neuroscience
-
Nov 20
Archaeology: Transition from tribal to feudal living in 14th century impacted local ecosystemsScientific Reports
-
Nov 18
Ecology: Migration associated with faster pace of lifeNature Communications
-
Nov 17
Gene therapy: Concerns for the long-term safety of AAV gene therapyNature Biotechnology
